Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Trevi Therapeutics Announces License Agreements for use of Nalbuphine for the Treatment of Levodopa-Induced Dyskinesia (LID) in Parkinson’s Disease
Tuesday, February 05, 2019Trevi Therapeutics Inc Trevi a clinicalstage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions today announced that it had entered into exclusive license ag...
Crescita Therapeutics Inc.™ and Tetra Natural Health Collaborate to Enhance Transdermal Delivery of Beta-Caryophyllene in Tetra's Dermatology Product Portfolio
Tuesday, February 05, 2019Crescita Therapeutics Inc a Canadian commercial dermatology company and Tetra Natural Health NHP a subsidiary of Tetra BioPharma a leader in cannabinoidderived drug discovery and development today announced an agreement to develop an enhanced version...
GeneQuantum Healthcare and MITRO Biotech Enter into Strategic Cooperation to Develop Next Generation Radionuclide Conjugates
Monday, February 04, 2019On February GeneQuantum Healthcare of Suzhou and MITRO Biotech of Nanjing signed the Strategic Cooperation Agreement on Next Generation Radionuclide Conjugates Development in Nanjing Dr Gang Qin President of GeneQuantum and Dr Xinping Li CEO of MIT...
MeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal Diseases
Saturday, February 02, 2019MeiraGTx Holdings plc a vertically integrated clinical stage gene therapy company today announced that it has entered into a broad strategic collaboration with Janssen Pharmaceuticals Inc Janssen one of the Janssen Pharmaceutical Companies of Johnson...
Fortress Biotech Announces CAEL-101 Strategic Partnership with Alexion Pharmaceuticals
Saturday, February 02, 2019Fortress Biotech Inc a biopharmaceutical company dedicated to acquiring developing and commercializing novel pharmaceutical and biotechnology products today announced that Caelum Biosciences Inc Caelum has signed a strategic agreement with Alexion Ph...
Alexion and Caelum Biosciences Announce Collaboration to Develop Targeted Therapy for Light Chain (AL) Amyloidosis
Friday, February 01, 2019Alexion Pharmaceuticals Inc and Caelum Biosciences today announced a collaboration to develop CAEL for light chain AL amyloidosis CAEL is a firstinclass amyloid fibril targeted therapy designed to improve organ function by reducing or eliminating amy...
Invenra and WARF Initiate a Collaboration to Discover and Develop Novel Therapeutics to Fight Neuroblastoma in Children
Friday, February 01, 2019Invenra and WARF Wisconsin Alumni Research Foundation today announced they have entered into a collaboration to discover and develop a bispecific antibody therapeutic for the treatment of neuroblastoma a cancer that is the third most common childhood...
Cannassure Therapeutics Announces Strategic Partnership With Cannika Holdings
Thursday, January 31, 2019Cannassure Therapeutics announces its collaboration with Cannika Holdings an agritech incubator specializing in cannabis innovation Cannika will operate out of the Cannassure campus utilizing their many facilities that are designed to meet the highes...
Repare Therapeutics Announces a Strategic Partnership Agreement With ONO Pharmaceutical Co., Ltd.
Thursday, January 31, 2019Repare Therapeutics Inc a privately held precision oncology company pioneering synthetic lethality to develop novel therapeutics that target specific vulnerabilities of tumors in clearly defined patient populations announced today that it has entered...
FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-class WDR5 Leukemia Therapy
Wednesday, January 30, 2019Triphase Accelerator together with its majority shareholder FACIT today announced a new strategic collaboration with Celgene for a firstinclass preclinical therapeutic targeting the WDR protein for the treatment of blood cancers including leukemia Tr...
